GMP consulting that cites the rule behind every gap
For drug, device, cosmetic and preclinical teams: a remote gap assessment against the GMP, GLP or data integrity rules that apply to you, with each finding cited to its requirement and ranked by risk.
Compliance that fits your product and your stage
Good manufacturing practice is not one rulebook. A sterile injectable, a wound dressing and a cosmetic serum answer to different regulations and inspectors. Our GMP consulting starts by naming the rules that apply to your products and markets. These may include 21 CFR Parts 210 and 211, EU GMP, ISO 13485, ISO 22716 or GLP. We then compare what your site does today with what those rules require.
GxP compliance also covers the data behind every release decision. Inspectors examine audit trails, user access and raw data as closely as batch records. We review paper and electronic records against ALCOA+ principles, 21 CFR Part 11 and EU GMP Annex 11. For device makers, we work to ISO 13485 and to FDA's Quality Management System Regulation, which has incorporated ISO 13485:2016 by reference since 2 February 2026.
Our GMP consulting draws on working knowledge of materials, sterilization, formulation and analytical science. That matters when a gap sits in a process rather than a procedure, such as an unvalidated cleaning step or a stability method that misses degradation. We advise and prepare. Your organization keeps ownership of its quality system and its regulatory decisions.
GMP and GxP support, from gap to closure
GMP gap assessment
A structured review of your site, processes and records against the regulations that apply to your product. Each gap is graded by risk to patients and product, with the failed requirement cited.
GLP readiness review
An assessment of a nonclinical test facility against 21 CFR Part 58 or the OECD Principles of GLP. It covers the study director role, quality assurance unit, equipment, test items and archives.
Data integrity assessment
A review of paper and electronic records against ALCOA+. We examine audit trails, user roles, shared logins, backups and review practices, and map each finding to Part 11 or Annex 11 expectations.
Design control and QMS review
For device makers, a review of design and development files, ISO 14971 risk management and QMS procedures against ISO 13485 and FDA's Quality Management System Regulation.
Remediation plan and procedures
A prioritized plan with owners, sequence and evidence of closure. Where useful, we draft or revise SOPs, forms and work instructions in your format for your quality unit to approve.
Training and CAPA support
Role-based training materials for GMP, good documentation practice, and record controls. We also help investigate deviations, find root causes and write corrective and preventive actions that address causes, not symptoms.
How a compliance engagement runs
Define scope and rules
We agree the products, sites, systems and markets in scope. From that we list the regulations and standards that apply. Every later finding then traces back to a stated requirement rather than an opinion.
Assess remotely
We review documents and ask process owners to describe how key procedures work in practice. For electronic systems, we review screenshots or exports of settings and audit trails alongside written procedures.
Report, plan and support
You receive a risk-graded report and a remediation plan sequenced for the resources you have. We stay available to draft procedures, train staff and check whether each correction was effective.
How compliance questions typically arrive
Cosmetic and personal care manufacturer
A cosmetic manufacturer preparing to make drug and device products
- Situation
- A manufacturer working to ISO 22716 cosmetic GMP plans to add an over-the-counter drug product and a simple medical device on the same site. Its documentation, validation and supplier controls were built for cosmetics. Nobody is sure how far they fall short.
- How we advise
- We would map the site against 21 CFR Parts 210 and 211 for the drug line and ISO 13485 for the device line. Typical gaps include process and cleaning validation, laboratory controls, complaint handling and design controls. Each gap would be graded by risk and effort to close. We would mark the items that must close before the first commercial batch.
- What you receive
- A gap assessment report with cited requirements, a sequenced remediation plan with owners, and a list of procedures to create or revise for each product line.
Contract preclinical laboratory
A preclinical laboratory asked to run studies under GLP
- Situation
- A laboratory with well-documented research studies is asked by a client to run a safety study under Good Laboratory Practice. It has capable scientists and equipment. It has no quality assurance unit, no formal master schedule and no archive that meets GLP expectations.
- How we advise
- We would assess the facility against 21 CFR Part 58 or the OECD Principles of GLP, depending on where the data will be submitted. We would define the study director and quality assurance roles, draft core SOPs and set up study plan and report templates. We would check equipment, test-item handling, and archive controls using records, photos, and written descriptions from staff before the first GLP study.
- What you receive
- A GLP readiness report, a core SOP set for the laboratory to adopt, role descriptions, and a checklist to complete before the first study starts.
Pharmaceutical quality control laboratory
Electronic laboratory records with unreviewed audit trails
- Situation
- A quality control laboratory relies on chromatography data systems and spreadsheets for release testing. An internal audit found shared user accounts and audit trails that were never reviewed. Management wants to know the full extent of the problem before an inspector finds it.
- How we advise
- We would review each system's configuration, user roles, audit trail settings and backups against ALCOA+, 21 CFR Part 11 and EU GMP Annex 11. We would sample records to trace results from raw data to the certificate of analysis. Findings would be ranked by data risk. Proposed controls could include unique logins, risk-based audit trail review and spreadsheet controls.
- What you receive
- A data integrity assessment by system, a risk-ranked remediation plan, and draft procedures for audit trail review and electronic record management.
Illustrative scenarios. Each is a composite of common client situations, not a specific engagement.
Start with a defined piece of work
Fixed scope · quoted on request
GMP/GxP Gap Assessment
A structured remote assessment of your site, processes and records against the GMP, GLP or data integrity requirements that apply, with risk-graded findings and a remediation plan.
Request a quoteFixed scope · quoted on request
Design Control & QMS Gap Review
A review of your design and development records and quality management system against ISO 13485, ISO 14971 and FDA requirements, with a ranked list of gaps and fixes.
Request a quoteFrequently asked questions
What is the difference between GMP and GxP?
GMP covers manufacturing and quality control. GxP is the umbrella term for good practices across the product life cycle, including laboratory, clinical and distribution practice. Most engagements start with manufacturing. Record-keeping and documentation rules apply across all of these practices, so we confirm early which ones apply to you.
What do you need from us before a gap assessment?
A short description of your products, markets and site, plus your quality manual, SOP index, organization chart and recent audit or inspection findings. Electronic record reviews also need a list of computerized systems and their validation status. Access to process owners matters more than polished documents.
How long does a GMP consulting assessment take?
Timing depends on the number of sites, product types and computerized systems in scope, and on how quickly documents and staff are available. A single site with one product line is far quicker than a multi-site review. We give a timeline in the written quote.
Can you certify our site or confirm we will pass an inspection?
No. ISO 13485 certificates come from certification bodies, and EU MDR quality system certificates from notified bodies. GMP and GLP compliance are judged by the relevant authorities through inspection. We assess your systems against stated requirements and help you close gaps. No consultant can promise an inspection outcome, and we do not.
Do you write our SOPs for us?
We can draft or revise SOPs, forms and work instructions in your format. Your quality unit reviews, approves and owns them, because procedures only work when they describe what staff actually do. We base drafts on your records, written input from staff, and descriptions of how each process works at your site.
Do you visit our site?
We assess your site remotely using documents, written responses from staff, and supporting records. For physical checks such as equipment status or storage conditions, we tell you what evidence to capture, such as photos, logs, or calibration records. The report identifies the evidence reviewed and any limitations.
Find your compliance gaps before an inspector does
Tell us your products, markets, and current quality system. We’ll confirm which requirements and records to review and send a written quote.
Neucite Consulting provides advisory support only; we do not certify facilities or quality systems, and compliance decisions and regulatory submissions remain the responsibility of your organization.